NCT04503382 is a NA clinical trial of Kindness Media in Altruism, sponsored by Envision Kindness Inc.

Who is sponsoring NCT04503382?

NCT04503382 is sponsored by Envision Kindness Inc.

What drugs are being tested in NCT04503382?

Interventions in NCT04503382: Kindness Media.

What condition does NCT04503382 study?

NCT04503382 studies Altruism, Behavior, Emotions.

Is NCT04503382 still recruiting?

NCT04503382 is currently completed. Last updated 22 March 2022.

Last reviewed 2022-03-22 · How we verify

NCT04503382

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Kindness Videos in Health Care Settings

Completed NA Last updated 22 March 2022

What this trial tests

NA trial testing Kindness Media in Altruism in 53 participants. Completed in 30 September 2020.

Timeline

1 May 2019

Primary endpoint
15 July 2020

30 September 2020

Quick facts

Lead sponsor	Envision Kindness Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	53
Start date	1 May 2019
Primary completion	15 July 2020
Estimated completion	30 September 2020
Sites	1 location across United States

Drugs / interventions tested

Kindness Media

Conditions studied

Altruism — all drugs for Altruism →
Behavior — all drugs for Behavior →
Emotions — all drugs for Emotions →

Sponsor

Envision Kindness Inc

Who can join

18 and older, any sex, with Altruism or Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study builds on earlier work assessing the impact of kindness media on viewers' emotional responses. Using images of kindness and connection, as well as other content, we will test its impact on emotions and behavior in the field. The setting is in healthcare, specifically a pediatric dental clinic. Using simple scales, participants anonymously rate themselves on a variety of emotions, watch a television for 8 minutes, and then complete the self-assessment. An honorarium is provided for participation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04503382 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Envision Kindness Inc
Last refreshed: 22 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04503382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing